EFNB2 and central nervous system cancer: In addition, knock down of the gene encoding for ephrins (EFNB2) in GSC derived from patients’ samples or treating tumours generated from these GSC with anti-ephrin-B2 antibodies, showed a significant reduction in the initiation and progression of glioma tumourigenesis.